During the past decade, Albany Associates in Cardiology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Albany Associates in Cardiology" #1 sponsor was "Medtronic Cardiac Rhythm and Heart Failure" with 2 trials, followed by "Angel Medical Systems" with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored, "CTI-1, LLC" with 1 trials sponsored and "Cardiovascular Clinical Studies" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Albany Associates in Cardiology" #1 collaborator was "GE Healthcare" with 2 trials as a collaborator, "GlaxoSmithKline" with 2 trials as a collaborator, "Medtronic" with 2 trials as a collaborator, "Abbott Medical Devices" with 1 trials as a collaborator and "Astellas Pharma US, Inc." with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Albany Associates in Cardiology" are "Atrial Fibrillation" (2 trials), "Congestive Heart Failure" (2 trials), "Coronary Artery Disease" (2 trials), "Heart Failure, Congestive" (2 trials) and "Myocardial Infarction" (2 trials). Many other conditions were trialed in "Albany Associates in Cardiology" in a lesser frequency.

Most popular intervention types in "Albany Associates in Cardiology" are "Drug" (6 trials), "Device" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Adenosine SPECT myocardial perfusion imaging" (1 trials), "Combined adenosine / exercise SPECT myocardial perfusion imaging" (1 trials), "Guardian System" (1 trials), "Left atrial ablation" (1 trials) and "Ranolazine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Albany Associates in Cardiology" are 9 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Albany Associates in Cardiology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Albany Associates in Cardiology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Albany Associates in Cardiology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".